Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Mestag Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Mestag Therapeutics's investors include SV Health Investors, Innovate UK, Johnson & Johnson Innovation JJDC.
Mestag Therapeutics is headquartered in Cambridge, United Kingdom.
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Mestag Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mestag Therapeutics — Funding & Investors." VCBacked, August 28, 2024, https://www.vcbacked.co/company/mestag-therapeutics-cambridge. Accessed October 21, 2026.
VCBacked. (2024). Mestag Therapeutics — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/mestag-therapeutics-cambridge
{{cite web |title=Mestag Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mestag-therapeutics-cambridge |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated